Episodes
-
Stigma in Epilepsy
Dr. Nikesh Ardeshna discusses the causes, consequences, and assessment of stigma in patients with epilepsy.
-
EEG Types and Settings
Dr. Selim Benbadis reviews the types and settings of EEG monitoring and the advantages and disadvantages of each method.
-
Psychogenic Non-Epileptic Events
In providing a brief overview of psychogenic non-epileptic events (PNEE), Dr. Ardeshna discusses presentation, risk factors, associated conditions, and treatment recommendations.
-
EEG Monitoring
Dr. Nikesh Ardeshna discusses routine EEG monitoring, video EEG monitoring, inpatient epilepsy monitoring units, and continuous EEG monitoring.
-
Comorbidities
Cognitive and mood comorbidities often coexist with epilepsy. Screening for and treating comorbid symptoms can often improve quality of life and may even impact seizure control.
-
SUDEP
Sudden unexplained death in epilepsy is a feared event in the course of epilepsy management and one about which much is still unknown. Possible causes and risks have been proposed, and prevention strategies exist, but more research is needed to better understand and prevent SUDEP.
-
Rational Polypharmacy
Epilepsy therapy is based on a accurate diagnosis and a clear understanding of seizure type. Monotherapy, adjunctive therapy, add-on therapy, and surgery are all treatment options, but choosing among them must be individualized.
-
First Seizure Guideline
Nikesh Ardeshna, MD, discusses the new AAN/AES guideline on management of an unprovoked first seizure in adults.
-
Heather Snyder, PhD
Dr. Snyder describes highlights from the research presented at the Alzheimer's Association International Conference 2018.
-
Russell Rosenberg, PhD
At SLEEP 2018, Dr. Rosenberg describes phase I trials that assessed patients' driving performance, ability to be awakened, and postural stability after taking the investigational sleep–wake regulation drug lemborexant, compared with active and placebo comparators.
-
Michael Alosco, PhD
Dr. Alosco discusses the association between age of exposure to tackle football and severity of CTE.
-
Mohammed Sanjak, PhD
Dr. Sanjak describes a proposed test for assessing lower-limb muscle strength in patients with ALS.
-
Thomas Edwards
Thomas Edwards discusses potential benefits of exercise in patients with MS with severe mobility disability.
-
Tracy E. Madsen, MD
Research suggests that the rate of stroke has declined for men, but not for women.
-
Selim Benbadis, MD
Dr. Benbadis describes the problem of overreading EEGs and how neurologists can avoid it.
-
Hugo Aparicio, MD
Dr. Aparicio describes the relationship between overweight status and survival after stroke.
-
Ricardo Jorge, MD
Dr. Jorge explains the impact of sertraline on depression following a traumatic brain injury (TBI).
-
Paulo Fontoura, MD, PhD
Dr. Fontoura examines the effect that ocrelizumab has on the composite end point of no evidence of disease progression in MS.
-
Ali Rezai, MD
Dr. Rezai describes how DBS may improve behavior and impulse control in patients with severe TBI.
-
Vladimir Hachinski, CM, MD, DSc
Dr. Hachinski discusses the relationship between stroke and dementia and how prevention efforts may affect the incidence of both diseases.
-
Bert B. Vargas, MD
Dr. Vargas discusses the neurologic risks inherent in professional football and how they might be mitigated.
-
Vijay Thadani, MD
Dr. Thadani discusses the range of neuromodulation strategies available for the treatment of seizures, proper patient selection, and treatment outcomes.
-
Samuel F. Hunter, MD, PhD
An open-label study indicates that patients with multiple sclerosis may benefit from switching to alemtuzumab.
-
Nikesh Ardeshna, MD
Dr. Ardeshna discusses the unique challenges posed by epilepsy in the rapidly expanding elderly population.
-
Clifford R. Jack, Jr., MD
Does amyloid accumulation cause the cognitive decline observed in middle age?
-
Michael D. Hill, MD
An investigator on the ESCAPE trial examines the current evidence for endovascular therapy in acute ischemic stroke.
-
Robert P. Cowan, MD
Dr. Cowan examines problems with the treatment of primary headache in the emergency department.
-
Stewart Tepper, MD, and Alan Rapoport, MD
At the 2015 HCOP conference, Dr. Tepper describes products in development that target CGRP to treat migraine.
-
Anne Berg, PhD
Dr. Anne Berg details what the literature says and does not say about the treatment of pediatric epilepsy.
-
Peter Goadsby, MD, PhD
Dr. Goadsby talks about CGRP and migraine at the 139th Annual Meeting of the American Neurological Association in Baltimore.
-
Gary Palmer, MD, and Kenneth Lowenberg
The Epilepsy Foundation and Eisai Inc. collaborated on a national survey of epilepsy patients and caregivers. Gary Palmer and Kenneth Lowenberg discuss the results of that survey and unmet needs in the epilepsy community.
-
Yohannes W. Woldeamanuel, MD
Dr. Woldeamanuel reviews the literature to evaluate the efficacy of corticosteroids as a treatment for migraine.
-
Mark Gudesblatt, MD
Dr. Gudesblatt discusses the benefits of the ReWalk Personal System for patients with lower-body paralysis resulting from spinal cord injury.
-
Peter L. Saltonstall, President and CEO of NORD
Peter Saltonstall discusses the history, mission, partnerships, and activities of the National Organization for Rare Disorders (NORD).
-
Robert Fox, MD
Robert Fox, MD, discusses NARCOMS and the NARCOMS Patient Registry.
-
Bert Vargas, MD
Bert Vargas, MD, compares two tools for evaluating sports-related concussion on the sidelines.
-
Fred Lublin, MD
Dr. Fred Lublin describes the US National Multiple Sclerosis Society's recent revisions to the clinical subtypes of multiple sclerosis.
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
Audio recordings from Neurology Reviews
Loading similar podcasts...